INTEGRATED CORE STRATEGIES (US) LLC - 31 Dec 2025 SCHEDULE 13G/A Report for Enanta Pharmaceuticals, Inc. Common Stock, par value $0.01 per share (ENTA)

Filing Manager
INTEGRATED CORE STRATEGIES (US) LLC
Reporting Manager
Millennium Management LLC
Security
Enanta Pharmaceuticals, Inc. Common Stock, par value $0.01 per share
Symbol
ENTA
Shares outstanding
29,149,043 shares
Disclosed Ownership
670,428 shares
Ownership
2.3%
Form type
SCHEDULE 13G/A
Filing time
20 Jan 2026, 16:42:25 UTC
Date of event
31 Dec 2025
Previous filing
13 Nov 2025
SEC
View on sec.gov

Sponsored

Quoteable Key Fact

"INTEGRATED CORE STRATEGIES (US) LLC disclosed 2.3% ownership in Enanta Pharmaceuticals, Inc. Common Stock, par value $0.01 per share (ENTA) on 31 Dec 2025."

Quick Takeaways

  • INTEGRATED CORE STRATEGIES (US) LLC filed SCHEDULE 13G/A for Enanta Pharmaceuticals, Inc. Common Stock, par value $0.01 per share (ENTA).
  • Disclosed ownership: 2.3%.
  • Date of event: 31 Dec 2025.

What Changed

  • Previous schedule filing date: 13 Nov 2025.
  • Current filing was accepted on 20 Jan 2026, 16:42.

Why This Matters

  • This page explains what this Schedule 13D/13G filing tells you before manager-level rows.
  • You can verify ownership claims directly against the original SEC filing.

Official SEC Source

Backed by Schedule 13D/13G

Beneficial ownership values are sourced from the original SEC Schedule 13D/13G filing.

See Original Filing

Reporting Managers (4)

Name Ownership Shares Owned sole voting power shared voting power Signature Title CIK
Integrated Core Strategies (US) LLC 2.3% 665,953 0 665,953 /s/ Gil Raviv Gil Raviv, Global General Counsel
Millennium Management LLC 2.3% 670,428 0 670,428 /s/ Gil Raviv Gil Raviv, Global General Counsel
Millennium Group Management LLC 2.3% 670,428 0 670,428 /s/ Gil Raviv Gil Raviv, Global General Counsel
Israel A. Englander 2.3% 670,428 0 670,428 /s/ Israel A. Englander Israel A. Englander

Sponsored